Another US Generic To $3bn Ibrance Passes Muster – When Will They Launch?
List Of ANDA Filers Waiting In The Wings, After Generics Reached India
A sizeable small-molecule opportunity, Pfizer’s Ibrance, is in the crosshairs for several major ANDA sponsors in the US, with Zydus the latest company to receive a tentative nod from the FDA.
